Results 31 to 40 of about 1,970,330 (303)

HPV vaccination: the beginning of the end of cervical cancer? - A Review

open access: yesMemorias do Instituto Oswaldo Cruz, 2009
Human papillomavirus (HPV) is responsible for all cases of cervical cancer, as well as a great percentage of other anogenital tumors and oropharyngeal tumors.
Ana Paula Lepique   +2 more
doaj   +1 more source

Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial [PDF]

open access: yes, 2010
Background: Current conventional vaccination approaches do not induce potent CD8 T-cell responses for fighting mostly variable viral diseases such as influenza, avian influenza viruses or HIV.
van der Werf, Sylvie   +26 more
core   +2 more sources

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

open access: yesFrontiers in Immunology, 2022
The CSF-470 vaccine (VACCIMEL) plus BCG and GM-CSF as adjuvants has been assayed in cutaneous melanoma patients. In the adjuvant randomized Phase II study CASVAC-0401, vaccinated patients had longer distant metastasis-free survival (DMFS) than those ...
Ana Mordoh   +10 more
doaj   +1 more source

Rhabdoviruses as vectors for vaccines and therapeutics [PDF]

open access: yesCurrent Opinion in Virology, 2020
Appropriate choice of vaccine vector is crucial for effective vaccine development. Rhabdoviral vectors, such as rabies virus and vesicular stomatitis virus, have been used in a variety of vaccine strategies. These viruses have small, easily manipulated genomes that can stably express foreign glycoproteins due to a well-established reverse genetics ...
Gabrielle Scher, Matthias J Schnell
openaire   +2 more sources

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses

open access: yes, 2008
Out of 98 subjects who had participated in the 2000 JE vaccination campaign, 69 people were enrolled in the tests of 2004 and 2005 for the evaluation of long term immune response of a single dose of live attenuated SA14-14-2 JE vaccine.
오희철
core   +1 more source

Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis

open access: yesHuman Vaccines & Immunotherapeutics, 2017
[Purpose] Multi-drug resistant (MDR), Mycobacterium tuberculosis (TB) is a big problem in the world. We have developed novel TB therapeutic vaccine (HVJ-E/HSP65 DNA +IL-12 DNA). [Methods and Results] DNA vaccine expressing TB heat shock protein 65 and IL-
Masaji Okada   +6 more
doaj   +1 more source

Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical

open access: yesExploration of Medicine, 2021
With the advent of various vaccines and antimicrobial agents during the 20th century, the control and containment of infectious diseases appeared to be a matter of time.
Sheikh Mohammad Fazle Akbar   +8 more
doaj   +1 more source

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

open access: yes, 2012
[[abstract]]Enterovirus 71 (EV71) has recently emerged as an important neurotropic virus in Asia because effective medications and prophylactic vaccine against EV71 infection are not available.
Chang, JY;Chang, CP;Tsai, HH;Lee, CD;Lian, WC;Ih Jen, S;Sai, IH;Liu, CC;Chou, AH;Lu, YJ;Chen, CY;Lee, PH;Chiang, JR;Chong, PC
core   +1 more source

A Scalable Protocol for Ex Vivo Production of CAR-Engineered Human NK Cells

open access: yesMethods and Protocols
Chimeric antigen receptor-expressing NK (CAR-NK) cells represent an advancing frontier in cancer immunotherapy, building upon decades of natural killer cell research and recent breakthroughs in CAR technology.
Supreet Khanal, Nirjal Bhattarai
doaj   +1 more source

Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy

open access: yesFrontiers in Pharmacology, 2022
Immunotherapy is an emerging method for the treatment of cervical cancer and is more effective than surgery and radiotherapy, especially for recurrent cervical cancer. However, immunotherapy is limited by adverse effects in clinical practice.
Xuyan Zhou   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy